Industry lobbyists are spending millions of euros to influence an upcoming EU decision on labelling titanium dioxide – found in everyday products like sunscreen – a “suspected carcinogen”. The lobbying is led by an unregistered trade association and a public relations consultancy; nonetheless, they appear to have the ear of member states and the European Commission.
Documents released to Corporate Europe Observatory following a Freedom of Information request reveal how pro-biotech lobby platform Public Research Regulation Initiative (PRRI) unites industry, researchers and regulators in ‘like-minded’ groups to influence crucial international biosafety talks under the UN Convention on Biological Diversity (CBD).
The plastics industry mounted a significant lobby campaign to influence the European Commission’s recent Plastics Strategy. Industry is now seeking to unpick or undermine key elements of the strategy through lacklustre or non-existing voluntary commitments, or outright opposition. With the Commission likely to publish its proposal to tackle single-use plastic products any day, will it adopt an ambitious approach towards binding regulations on industry?